IDEAS home Printed from https://ideas.repec.org/a/sae/evarev/v22y1998i2p155-174.html
   My bibliography  Save this article

Model-Based Evaluation of Hiv Prevention Interventions

Author

Listed:
  • Steven D. Pinkerton

    (Medical College of Wisconsin)

  • David R. Holtgrave

    (Medical College of Wisconsin)

  • Laura C. Leviton

    (University of Alabama School of Public Health)

  • David A. Wagstaff

    (Medical College of Wisconsin)

  • Paul R. Abramson

    (University of California, Los Angeles)

Abstract

The ultimate goal of HIV prevention interventions is to reduce the spread of HIV; however, the effectiveness of these programs is seldom assessed directly. Although direct measurement of an intervention's impact via HIV seroincidence monitoring is usually unfeasible, mathematical models can be used to estimate the number of infections averted by the intervention. This article describes three model-based summary measures of sexually transmitted HIV risk and discusses their relevance to HIV program evaluation m general and economic efficiency analyses in particular. The calculation of these measures is demonstrated with an illustrative application to previously published data from an HIV prevention intervention for gay men.

Suggested Citation

  • Steven D. Pinkerton & David R. Holtgrave & Laura C. Leviton & David A. Wagstaff & Paul R. Abramson, 1998. "Model-Based Evaluation of Hiv Prevention Interventions," Evaluation Review, , vol. 22(2), pages 155-174, April.
    • Handle: RePEc:sae:evarev:v:22:y:1998:i:2:p:155-174
    DOI: 10.1177/0193841X9802200201
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/0193841X9802200201
    Download Restriction: no
    File URL: https://libkey.io/10.1177/0193841X9802200201?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Holtgrave, D.R. & Kelly, J.A., 1996. "Preventing HIV/AIDS among high-risk urban women: The cost-effectiveness of a behavioral group intervention," American Journal of Public Health, American Public Health Association, vol. 86(10), pages 1442-1445.
    2. Holmberg, S.D., 1996. "The estimated prevalence and incidence of HIV in 96 large US metropolitan areas," American Journal of Public Health, American Public Health Association, vol. 86(5), pages 642-654.
    3. Fishbein, M., 1996. "Great expectations, or do we ask too much from community-level interventions?," American Journal of Public Health, American Public Health Association, vol. 86(8), pages 1075-1076.
    4. Mays, Vickie M. & Jackson, James S., 1991. "AIDS survey methodology with black Americans," Social Science & Medicine, Elsevier, vol. 33(1), pages 47-54, January.
    5. Pinkerton, Steven D. & Abramson, Paul R., 1997. "Effectiveness of condoms in preventing HIV transmission," Social Science & Medicine, Elsevier, vol. 44(9), pages 1303-1312, May.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ana P. Johnson-Masotti & Purushottam W. Laud & Raymond G. Hoffmann & Matthew J. Hayat & Steven D. Pinkerton, 2001. "Probabilistic Cost-Effectiveness Analysis of HIV Prevention," Evaluation Review, , vol. 25(4), pages 474-502, August.
    2. Ana P. Johnson-Masotti & Purushottam W. Laud & Raymond G. Hoffmann & Matthew J. Hayat & Steven D. Pinkerton, 2004. "A Bayesian Approach to Net Health Benefits: An Illustration and Application to Modeling HIV Prevention," Medical Decision Making, , vol. 24(6), pages 634-653, November.
    3. Schilling, Robert F. & Fernando, Daniel & Fontdevila, Jorge & El-Bassel, Nabila, 2000. "HIV risk reduction among injection drug users: explaining the lack of anticipated outcomes in a community-level controlled comparison study," Evaluation and Program Planning, Elsevier, vol. 23(3), pages 301-313, August.
    4. A. David Paltiel & Harold A. Pollack, 2010. "Price, Performance, and the FDA Approval Process: The Example of Home HIV Testing," Medical Decision Making, , vol. 30(2), pages 217-223, March.
    5. Stephanie Earnshaw & Katherine Hicks & Anke Richter & Amanda Honeycutt, 2007. "A linear programming model for allocating HIV prevention funds with state agencies: a pilot study," Health Care Management Science, Springer, vol. 10(3), pages 239-252, September.
    6. Jeremy Greenwood & Nezih Guner, 2010. "Social Change: The Sexual Revolution," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 51(4), pages 893-923, November.
    7. Jeremy Greenwood & Nezih Guner, 2006. "Social Change," 2006 Meeting Papers 79, Society for Economic Dynamics.
    8. Masunga K. Iseselo & Edith A. M. Tarimo & Eric Sandstrom & Asli Kulane, 2020. "Sexual Behaviours and Practices before and after Phase I/II HIV Vaccine Trial: A Qualitative Study among Volunteers in Dar es Salaam Tanzania," IJERPH, MDPI, vol. 17(19), pages 1-20, October.
    9. Wilson, Amy R. & Kahn, James G., 2003. "Preventing HIV in injection drug users: exploring the tradeoffs between interventions," Socio-Economic Planning Sciences, Elsevier, vol. 37(4), pages 269-288, December.
    10. Steven D. Pinkerton & Eric G. Benotsch & John Mikytuck, 2007. "When Do Simpler Sexual Behavior Data Collection Techniques Suffice?," Evaluation Review, , vol. 31(4), pages 401-412, August.
    11. Georgiy Bobashev & Sarah Mars & Nicholas Murphy & Clinton Dreisbach & William Zule & Daniel Ciccarone, 2019. "Heroin type, injecting behavior, and HIV transmission. A simulation model of HIV incidence and prevalence," PLOS ONE, Public Library of Science, vol. 14(12), pages 1-17, December.
    12. Lessner, Lawrence, 2008. "HIV prevalence for New York State using Newborn Seroprevalence and AIDS Surveillance Data," Socio-Economic Planning Sciences, Elsevier, vol. 42(4), pages 286-299, December.
    13. Steven D. Pinkerton & Harrell W. Chesson & David R. Holtgrave & William Kassler & Peter M. Layde, 2000. "When is an HIV Infection Prevented and when is it Merely Delayed?," Evaluation Review, , vol. 24(3), pages 251-271, June.
    14. Amanda Srsic & Katarzyna Dubas-Jakóbczyk & Ewa Kocot, 2021. "The Economic Consequences of Decriminalizing Sex Work in Washington, DC—A Conceptual Model," Societies, MDPI, vol. 11(3), pages 1-23, September.
    15. Bimala Sharma & Eun Woo Nam, 2018. "Condom Use at Last Sexual Intercourse and Its Correlates among Males and Females Aged 15–49 Years in Nepal," IJERPH, MDPI, vol. 15(3), pages 1-17, March.
    16. Schilling, Robert F. & Fontdevila, Jorge & Fernando, Daniel & El-Bassel, Nabila & Monterroso, Edgar, 2004. "Proximity to needle exchange programs and HIV-related risk behavior among injection drug users in Harlem," Evaluation and Program Planning, Elsevier, vol. 27(1), pages 25-33, February.
    17. Fern Terris‐Prestholt & Matthew Quaife & Peter Vickerman, 2016. "Parameterising User Uptake in Economic Evaluations: The role of discrete choice experiments," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 116-123, February.
    18. David R. Holtgrave, 2004. "HIV Prevention, Cost-Utility Analysis, and Race/Ethnicity: Methodological Considerations and Recommendations," Medical Decision Making, , vol. 24(2), pages 181-191, March.
    19. Iguchi, Martin Y. & Bux, Donald A. & Kushner, Harvey & Lidz, Victor, 2001. "Correlates of HIV risk among female sex partners of injecting drug users in a high-seroprevalence area," Evaluation and Program Planning, Elsevier, vol. 24(2), pages 175-185, May.
    20. Sabina S Alistar & Douglas K Owens & Margaret L Brandeau, 2014. "Effectiveness and Cost Effectiveness of Oral Pre-Exposure Prophylaxis in a Portfolio of Prevention Programs for Injection Drug Users in Mixed HIV Epidemics," PLOS ONE, Public Library of Science, vol. 9(1), pages 1-11, January.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:evarev:v:22:y:1998:i:2:p:155-174. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.